LOGIN
Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls
January 2019
Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls
Study Type:Meta-analysis/Systematic Review
OE Level Evidence:1
Journal Level of Evidence:N/A
Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and metaanalysis
Expert Opin Drug Saf. 2018 Apr;17(4):413-428Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
6 randomized controlled trials were included in this meta-analysis which aimed to compare increase in bone mineral density measurements between denosumab and other active anti-osteoporosis medications among postmenopausal women with osteoporosis and who had previously been administered anti-osteoporosis therapy. In pooled analyses, percent increase in bone mineral density measured at the total hip...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.